Biomarker Precision
Alamar Biosciences' mission is to enable early detection of disease through automated protein analysis across a wide range of multiplex levels, supporting the translation of critical biomarkers from discovery through to clinical research. Their first product has become a scientific and commercial success.
The inherent complexity of this highly engineered product needed to be transformed into a welcoming, intuitive experience - distinct from anything currently available on the market.
The final design integrates multiple design elements that highlight the product’s groundbreaking novelty while ensuring ease of maintenance and manufacturability.
$1.5 billion
After several funding rounds supported by the design of the maiden product, Alamar Biosciences debuted at Nasdaq with a value of $1.5 billion in shares.
Industrial Design
Visualisation
CMF
User Interface
Other work
